{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T12:57:31Z","timestamp":1790945851532,"version":"4.1.0"},"reference-count":142,"publisher":"European Respiratory Society (ERS)","issue":"166","license":[{"start":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T00:00:00Z","timestamp":1671580800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["Eur Respir Rev"],"accepted":{"date-parts":[[2022,10,21]]},"published-print":{"date-parts":[[2022,12,31]]},"abstract":"<jats:p>Sarcoidosis is an immune-mediated disorder. Its immunopathology has been steadily mapped out over the past few decades. Despite this, the underpinning mechanisms for progressive fibrotic sarcoidosis is an almost uncharted area. Consequently, there has been little change in the clinical management of fibrotic sarcoidosis over the decades and an unfocused search for new therapeutics. In this review, we provide a comprehensive examination of the relevant immune findings in fibrotic and\/or progressive pulmonary sarcoidosis and propose a unifying mechanism for the pathobiology of fibrosis in sarcoidosis.<\/jats:p>","DOI":"10.1183\/16000617.0178-2022","type":"journal-article","created":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T09:40:14Z","timestamp":1671615614000},"page":"220178","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":19,"title":["Immune mechanisms in fibrotic pulmonary sarcoidosis"],"prefix":"10.1183","volume":"31","author":[{"given":"Praveen","family":"Weeratunga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Moller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling-Pei","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2022,12,21]]},"reference":[{"key":"2024102404085573000_31.166.220178.1","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2010.140319"},{"key":"2024102404085573000_31.166.220178.2","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01124-2017"},{"key":"2024102404085573000_31.166.220178.3","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201507-1499OC"},{"key":"2024102404085573000_31.166.220178.4","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20050648"},{"key":"2024102404085573000_31.166.220178.5","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.rmed.2009.11.008","article-title":"Deficiency of pulmonary V\u03b124 V\u03b211 natural killer T cells in corticosteroid-na\u00efve sarcoidosis patients","volume":"104","author":"Korosec","year":"2010","journal-title":"Respir Med"},{"key":"2024102404085573000_31.166.220178.6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)71143-0"},{"key":"2024102404085573000_31.166.220178.7","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3655"},{"key":"2024102404085573000_31.166.220178.8","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.it.2020.01.007","article-title":"Sarcoidosis and the mTOR, Rac1, and autophagy triad","volume":"41","author":"Pacheco","year":"2020","journal-title":"Trends Immunol"},{"key":"2024102404085573000_31.166.220178.9","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41572-019-0096-x","article-title":"Sarcoidosis","volume":"5","author":"Grunewald","year":"2019","journal-title":"Nat Rev Dis Primers"},{"key":"2024102404085573000_31.166.220178.10","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.04079-2020"},{"key":"2024102404085573000_31.166.220178.11","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.160.2.ats4-99"},{"key":"2024102404085573000_31.166.220178.12","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2019-214348"},{"key":"2024102404085573000_31.166.220178.13","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/MCP.0000000000000301","article-title":"From granuloma to fibrosis: sarcoidosis associated pulmonary fibrosis","volume":"22","author":"Bonham","year":"2016","journal-title":"Curr Opin Pulm Med"},{"key":"2024102404085573000_31.166.220178.14","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201303-069FR"},{"key":"2024102404085573000_31.166.220178.15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1908681"},{"key":"2024102404085573000_31.166.220178.16","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00187410"},{"key":"2024102404085573000_31.166.220178.17","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S2213-2600(13)70276-5","article-title":"An integrated clinicoradiological staging system for pulmonary sarcoidosis: a case-cohort study","volume":"2","author":"Walsh","year":"2014","journal-title":"Lancet Respir Med"},{"key":"2024102404085573000_31.166.220178.18","doi-asserted-by":"publisher","DOI":"10.1378\/chest.122.1.233"},{"key":"2024102404085573000_31.166.220178.19","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.46.538.530"},{"key":"2024102404085573000_31.166.220178.20","doi-asserted-by":"publisher","DOI":"10.1097\/01.bor.0000137894.63091.1a"},{"key":"2024102404085573000_31.166.220178.21","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2014.137"},{"key":"2024102404085573000_31.166.220178.22","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2807"},{"key":"2024102404085573000_31.166.220178.23","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20030917"},{"key":"2024102404085573000_31.166.220178.24","doi-asserted-by":"publisher","DOI":"10.1378\/chest.129.6.1584"},{"key":"2024102404085573000_31.166.220178.25","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00120410"},{"key":"2024102404085573000_31.166.220178.26","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.98.12040913"},{"key":"2024102404085573000_31.166.220178.27","first-page":"213","article-title":"Circulatory TGF-\u03b21 is significantly higher in early stage of pulmonary sarcoidosis","volume":"35","author":"Mehdi","year":"2018","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2024102404085573000_31.166.220178.28","doi-asserted-by":"crossref","first-page":"046003","DOI":"10.1088\/1752-7155\/7\/4\/046003","article-title":"Measurement of neopterin, TGF-\u03b21 and ACE in the exhaled breath condensate of patients with sarcoidosis","volume":"7","author":"Ahmadzai","year":"2013","journal-title":"J Breath Res"},{"key":"2024102404085573000_31.166.220178.29","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2010-0070OC"},{"key":"2024102404085573000_31.166.220178.30","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200706-945OC"},{"key":"2024102404085573000_31.166.220178.31","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0039.2010.01590.x"},{"key":"2024102404085573000_31.166.220178.32","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.cell.2020.02.041","article-title":"Toll-like receptors and the control of immunity","volume":"180","author":"Fitzgerald","year":"2020","journal-title":"Cell"},{"key":"2024102404085573000_31.166.220178.33","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200905-0696OC"},{"key":"2024102404085573000_31.166.220178.34","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-008-9225-0"},{"key":"2024102404085573000_31.166.220178.35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000474"},{"key":"2024102404085573000_31.166.220178.36","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2007.03428.x"},{"key":"2024102404085573000_31.166.220178.37","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0039.2011.01808.x"},{"key":"2024102404085573000_31.166.220178.38","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201304-0760OC"},{"key":"2024102404085573000_31.166.220178.39","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1093\/qjmed\/hcx243","article-title":"Toll-like receptor 3 L412F polymorphism promotes a persistent clinical phenotype in pulmonary sarcoidosis","volume":"111","author":"Cooke","year":"2018","journal-title":"QJM"},{"key":"2024102404085573000_31.166.220178.40","doi-asserted-by":"publisher","DOI":"10.1038\/ng.198"},{"key":"2024102404085573000_31.166.220178.41","doi-asserted-by":"publisher","DOI":"10.1038\/gene.2012.48"},{"key":"2024102404085573000_31.166.220178.42","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2010.138743"},{"key":"2024102404085573000_31.166.220178.43","doi-asserted-by":"publisher","DOI":"10.1038\/gene.2011.27"},{"key":"2024102404085573000_31.166.220178.44","first-page":"P777","article-title":"Is a functional variant of ANXA11 R230C associated with impaired apoptosis? Pilot data","volume":"40","author":"Fillerova","year":"2012","journal-title":"Eur Respir J"},{"key":"2024102404085573000_31.166.220178.45","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0039.2010.01590.x"},{"key":"2024102404085573000_31.166.220178.46","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200912-1855OC"},{"key":"2024102404085573000_31.166.220178.47","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0506580102"},{"key":"2024102404085573000_31.166.220178.48","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201106-1143OC"},{"key":"2024102404085573000_31.166.220178.49","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2019.07.007"},{"key":"2024102404085573000_31.166.220178.50","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.623430"},{"key":"2024102404085573000_31.166.220178.51","doi-asserted-by":"crossref","first-page":"595811","DOI":"10.3389\/fimmu.2021.595811","article-title":"Disparate interferon signaling and shared aberrant basaloid cells in single-cell profiling of idiopathic pulmonary fibrosis and systemic sclerosis-associated interstitial lung disease","volume":"12","author":"Valenzi","year":"2021","journal-title":"Front Immunol"},{"key":"2024102404085573000_31.166.220178.52","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2012.03.008"},{"key":"2024102404085573000_31.166.220178.53","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1843.2005.00746.x"},{"key":"2024102404085573000_31.166.220178.54","doi-asserted-by":"crossref","first-page":"2002950","DOI":"10.1183\/13993003.02950-2020","article-title":"Transcriptomics of bronchoalveolar lavage cells identifies new molecular endotypes of sarcoidosis","volume":"58","author":"Vukmirovic","year":"2021","journal-title":"Eur Respir J"},{"key":"2024102404085573000_31.166.220178.55","doi-asserted-by":"publisher","DOI":"10.1126\/science.abg7292"},{"key":"2024102404085573000_31.166.220178.56","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.02.004"},{"key":"2024102404085573000_31.166.220178.57","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02695-2020"},{"key":"2024102404085573000_31.166.220178.58","doi-asserted-by":"crossref","first-page":"567342","DOI":"10.3389\/fimmu.2020.567342","article-title":"Single cell transcriptomics implicate novel monocyte and T cell immune dysregulation in sarcoidosis","volume":"11","author":"Garman","year":"2020","journal-title":"Front Immunol"},{"key":"2024102404085573000_31.166.220178.59","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.03794-2020"},{"key":"2024102404085573000_31.166.220178.60","first-page":"83","article-title":"HLA and sarcoidosis: new pathogenetic insights","volume":"19","author":"Martinetti","year":"2002","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2024102404085573000_31.166.220178.61","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00621-2021"},{"key":"2024102404085573000_31.166.220178.62","doi-asserted-by":"publisher","DOI":"10.1186\/s10020-018-0047-0"},{"key":"2024102404085573000_31.166.220178.63","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200905-0696OC"},{"key":"2024102404085573000_31.166.220178.64","doi-asserted-by":"crossref","first-page":"585","DOI":"10.3390\/cells10030585","article-title":"Elevated serum amyloid A levels are not specific for sarcoidosis but associate with a fibrotic pulmonary phenotype","volume":"10","author":"Beijer","year":"2021","journal-title":"Cells"},{"key":"2024102404085573000_31.166.220178.65","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.resinv.2019.03.010","article-title":"Serum amyloid A in patients with idiopathic pulmonary fibrosis","volume":"57","author":"Vietri","year":"2019","journal-title":"Respir Investig"},{"key":"2024102404085573000_31.166.220178.66","doi-asserted-by":"crossref","first-page":"109238","DOI":"10.18632\/oncotarget.22652","article-title":"Serum amyloid a induces M2b-like macrophage polarization during liver inflammation","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"key":"2024102404085573000_31.166.220178.67","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2015.08.061"},{"key":"2024102404085573000_31.166.220178.68","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2003-0078OC"},{"key":"2024102404085573000_31.166.220178.69","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.4049\/jimmunol.160.3.1411","article-title":"Alternative macrophage activation-associated CC-chemokine-1, a novel structural homologue of macrophage inflammatory protein-1 \u03b1 with a Th2-associated expression pattern","volume":"160","author":"Kodelja","year":"1998","journal-title":"J Immunol"},{"key":"2024102404085573000_31.166.220178.70","doi-asserted-by":"publisher","DOI":"10.1002\/art.21950"},{"key":"2024102404085573000_31.166.220178.71","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200808-1201OC"},{"key":"2024102404085573000_31.166.220178.72","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200509-1518OC"},{"key":"2024102404085573000_31.166.220178.73","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2010.06.017"},{"key":"2024102404085573000_31.166.220178.74","doi-asserted-by":"crossref","first-page":"13048","DOI":"10.1038\/ncomms13048","article-title":"Tiam1\/Rac1 complex controls Il17\u03b1 transcription and autoimmunity","volume":"7","author":"Kurdi","year":"2016","journal-title":"Nat Commun"},{"key":"2024102404085573000_31.166.220178.75","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S2213-2600(18)30508-3","article-title":"Increased monocyte count as a cellular biomarker for poor outcomes in fibrotic diseases: a retrospective, multicentre cohort study","volume":"7","author":"Scott","year":"2019","journal-title":"Lancet Respir Med"},{"key":"2024102404085573000_31.166.220178.76","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.03468-2020"},{"key":"2024102404085573000_31.166.220178.77","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-physiol-022516-034339"},{"key":"2024102404085573000_31.166.220178.78","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2016.02.024"},{"key":"2024102404085573000_31.166.220178.79","doi-asserted-by":"publisher","DOI":"10.1126\/science.aau0964"},{"key":"2024102404085573000_31.166.220178.80","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.humimm.2017.10.009","article-title":"Evidence for M2 macrophages in granulomas from pulmonary sarcoidosis: a new aspect of macrophage heterogeneity","volume":"79","author":"Shamaei","year":"2018","journal-title":"Hum Immunol"},{"key":"2024102404085573000_31.166.220178.81","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.congress-2019.PA4694"},{"key":"2024102404085573000_31.166.220178.82","doi-asserted-by":"crossref","first-page":"4005","DOI":"10.21037\/jtd.2019.09.03","article-title":"Elevation of pulmonary CD163+ and CD204+ macrophages is associated with the clinical course of idiopathic pulmonary fibrosis patients","volume":"11","author":"Nouno","year":"2019","journal-title":"J Thorac Dis"},{"key":"2024102404085573000_31.166.220178.83","doi-asserted-by":"crossref","first-page":"719009","DOI":"10.3389\/fimmu.2021.719009","article-title":"Hypoxia promotes a mixed inflammatory-fibrotic macrophages phenotype in active sarcoidosis","volume":"12","author":"Jeny","year":"2021","journal-title":"Front Immunol"},{"key":"2024102404085573000_31.166.220178.84","doi-asserted-by":"crossref","first-page":"e44519","DOI":"10.7554\/eLife.44519","article-title":"HIF-1\u03b1 regulates IL-1\u03b2 and IL-17 in sarcoidosis","volume":"8","author":"Talreja","year":"2019","journal-title":"eLife"},{"key":"2024102404085573000_31.166.220178.85","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20092121"},{"key":"2024102404085573000_31.166.220178.86","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0902446"},{"key":"2024102404085573000_31.166.220178.87","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2011.03482.x"},{"key":"2024102404085573000_31.166.220178.88","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexmp.2009.06.001"},{"key":"2024102404085573000_31.166.220178.89","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.immuni.2019.02.001","article-title":"Dysregulated lung commensal bacteria drive interleukin-17B production to promote pulmonary fibrosis through their outer membrane vesicles","volume":"50","author":"Yang","year":"2019","journal-title":"Immunity"},{"key":"2024102404085573000_31.166.220178.90","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201503-0418OC"},{"key":"2024102404085573000_31.166.220178.91","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0023185"},{"key":"2024102404085573000_31.166.220178.92","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1004081"},{"key":"2024102404085573000_31.166.220178.93","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20130301"},{"key":"2024102404085573000_31.166.220178.94","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.2011.02414.x"},{"key":"2024102404085573000_31.166.220178.95","doi-asserted-by":"publisher","DOI":"10.1016\/j.resinv.2012.07.001"},{"key":"2024102404085573000_31.166.220178.96","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ker316"},{"key":"2024102404085573000_31.166.220178.97","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1007\/s10875-012-9817-6","article-title":"Sarcoidosis Th17 cells are ESAT-6 antigen specific but demonstrate reduced IFN-\u03b3 expression","volume":"33","author":"Richmond","year":"2013","journal-title":"J Clin Immunol"},{"key":"2024102404085573000_31.166.220178.98","doi-asserted-by":"publisher","DOI":"10.1111\/cei.12403"},{"key":"2024102404085573000_31.166.220178.99","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00092-2016"},{"key":"2024102404085573000_31.166.220178.100","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aar8356"},{"key":"2024102404085573000_31.166.220178.101","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201401-0188OC"},{"key":"2024102404085573000_31.166.220178.102","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.jtho.2018.04.031","article-title":"Sarcoidosis-like reactions induced by checkpoint inhibitors","volume":"13","author":"Gkiozos","year":"2018","journal-title":"J Thorac Oncol"},{"key":"2024102404085573000_31.166.220178.103","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-7-35"},{"key":"2024102404085573000_31.166.220178.104","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-11-120998"},{"key":"2024102404085573000_31.166.220178.105","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1111\/1756-185X.13076","article-title":"Immunotherapy-induced sarcoidosis in patients with melanoma treated with PD-1 checkpoint inhibitors: case series and immunophenotypic analysis","volume":"20","author":"Lomax","year":"2017","journal-title":"Int J Rheum Dis"},{"key":"2024102404085573000_31.166.220178.106","first-page":"S37","article-title":"Pulmonary fibrosis of sarcoidosis. New approaches, old ideas","volume":"29","author":"Moller","year":"2003","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2024102404085573000_31.166.220178.107","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.74.3.1471-1479.2006"},{"key":"2024102404085573000_31.166.220178.108","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1521-4141(199809)28:09<2619::AID-IMMU2619>3.0.CO;2-M"},{"key":"2024102404085573000_31.166.220178.109","doi-asserted-by":"publisher","DOI":"10.1172\/JCI7325"},{"key":"2024102404085573000_31.166.220178.110","doi-asserted-by":"publisher","DOI":"10.1084\/jem.194.6.809"},{"key":"2024102404085573000_31.166.220178.111","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1003260"},{"key":"2024102404085573000_31.166.220178.112","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.173.6.4020"},{"key":"2024102404085573000_31.166.220178.113","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.cyto.2012.12.016","article-title":"Circulating cytokines in sarcoidosis: phenotype-specific alterations for fibrotic and non-fibrotic pulmonary disease","volume":"61","author":"Patterson","year":"2013","journal-title":"Cytokine"},{"key":"2024102404085573000_31.166.220178.114","doi-asserted-by":"publisher","DOI":"10.1136\/thorax.58.6.519"},{"key":"2024102404085573000_31.166.220178.115","doi-asserted-by":"publisher","DOI":"10.1165\/ajrcmb.24.5.4064"},{"key":"2024102404085573000_31.166.220178.116","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00303.2002"},{"key":"2024102404085573000_31.166.220178.117","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)60551-1"},{"key":"2024102404085573000_31.166.220178.118","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa030511"},{"key":"2024102404085573000_31.166.220178.119","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.25.022106.141623"},{"key":"2024102404085573000_31.166.220178.120","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200812-1936OC"},{"key":"2024102404085573000_31.166.220178.121","doi-asserted-by":"publisher","DOI":"10.1172\/JCI37662"},{"key":"2024102404085573000_31.166.220178.122","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e328349c62d"},{"key":"2024102404085573000_31.166.220178.123","doi-asserted-by":"publisher","DOI":"10.1016\/j.trim.2010.09.002"},{"key":"2024102404085573000_31.166.220178.124","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2009.12.013"},{"key":"2024102404085573000_31.166.220178.125","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/cei.12715","article-title":"Pulmonary sarcoidosis is associated with high-level inducible co-stimulator (ICOS) expression on lung regulatory T cells\u2013possible implications for the ICOS\/ICOS\u2013ligand axis in disease course and resolution","volume":"183","author":"Sakthivel","year":"2016","journal-title":"Clin Exp Immunol"},{"key":"2024102404085573000_31.166.220178.126","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1202891"},{"key":"2024102404085573000_31.166.220178.127","doi-asserted-by":"crossref","first-page":"e0148207","DOI":"10.1371\/journal.pone.0148207","article-title":"The circulating Treg\/th17 cell ratio is correlated with relapse and treatment response in pulmonary sarcoidosis patients after corticosteroid withdrawal","volume":"11","author":"Liu","year":"2016","journal-title":"PLoS One"},{"key":"2024102404085573000_31.166.220178.128","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1164\/rccm.201503-0635LE","article-title":"Decreased cytotoxic T-lymphocyte antigen 4 expression on regulatory T cells and Th17 cells in sarcoidosis: double trouble?","volume":"192","author":"Broos","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"2024102404085573000_31.166.220178.129","doi-asserted-by":"publisher","DOI":"10.1093\/jmcb\/mjr033"},{"key":"2024102404085573000_31.166.220178.130","doi-asserted-by":"publisher","DOI":"10.1038\/nri1571"},{"key":"2024102404085573000_31.166.220178.131","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1038\/s41590-020-0741-2","article-title":"The mesenchymal context in inflammation, immunity and cancer","volume":"21","author":"Koliaraki","year":"2020","journal-title":"Nat Immunol"},{"key":"2024102404085573000_31.166.220178.132","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/PL00007596","article-title":"Fibroblasts as target and effector cells in Japanese patients with sarcoidosis","volume":"176","author":"Tamura","year":"1998","journal-title":"Lung"},{"key":"2024102404085573000_31.166.220178.133","doi-asserted-by":"crossref","first-page":"644","DOI":"10.3390\/cells11040664","article-title":"Comparative analysis of gene expression in fibroblastic foci in patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis","volume":"11","author":"Kamp","year":"2022","journal-title":"Cells"},{"key":"2024102404085573000_31.166.220178.134","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1165\/rcmb.2018-0177OC","article-title":"DNA methylation changes in lung immune cells are associated with granulomatous lung disease","volume":"60","author":"Yang","year":"2018","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2024102404085573000_31.166.220178.135","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e3182785a2d"},{"key":"2024102404085573000_31.166.220178.136","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00150609"},{"key":"2024102404085573000_31.166.220178.137","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1002\/eji.201344284","article-title":"Abnormalities in iNKT cells are associated with impaired ability of monocytes to produce IL-10 and suppress T-cell proliferation in sarcoidosis","volume":"44","author":"Crawshaw","year":"2014","journal-title":"Eur J Immunol"},{"key":"2024102404085573000_31.166.220178.138","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s00441-016-2526-3","article-title":"Animal models of sarcoidosis","volume":"367","author":"Hu","year":"2017","journal-title":"Cell Tissue Res"},{"key":"2024102404085573000_31.166.220178.139","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-07-6307"},{"key":"2024102404085573000_31.166.220178.140","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2002.124259"},{"key":"2024102404085573000_31.166.220178.141","doi-asserted-by":"publisher","DOI":"10.1126\/science.290.5489.127"},{"key":"2024102404085573000_31.166.220178.142","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.cyto.2013.12.003","article-title":"Peripheral depletion of NK cells and imbalance of the Treg\/Th17 axis in idiopathic pulmonary fibrosis patients","volume":"66","author":"Galati","year":"2014","journal-title":"Cytokine"}],"updated-by":[{"DOI":"10.1183\/16000617.5178-2022","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T00:00:00Z","timestamp":1692748800000}}],"container-title":["European Respiratory Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/16000617.0178-2022","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T05:06:20Z","timestamp":1740373580000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/16000617.0178-2022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,21]]},"references-count":142,"journal-issue":{"issue":"166","published-online":{"date-parts":[[2022,12,21]]},"published-print":{"date-parts":[[2022,12,31]]}},"alternative-id":["10.1183\/16000617.0178-2022"],"URL":"https:\/\/doi.org\/10.1183\/16000617.0178-2022","relation":{"correction":[{"id-type":"doi","id":"10.1183\/16000617.5178-2022","asserted-by":"object"}]},"ISSN":["0905-9180","1600-0617"],"issn-type":[{"value":"0905-9180","type":"print"},{"value":"1600-0617","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,21]]}}}